Reduced Incidence of Necrotizing Enterocolitis due to the Anti-Inflammatory Effects of CXCL14 in Intestinal Tissue

J Healthc Eng. 2022 Apr 14:2022:1322172. doi: 10.1155/2022/1322172. eCollection 2022.

Abstract

Bioinformatic analysis indicated that downregulated CXCL14 will occur in the intestinal tissue of patients with necrotizing enterocolitis (NEC). To reveal the relationship between CXCL14 and mucosal immune regulation, we designed and implemented the experiments to explore the potential function of CXCL14 in the pathogenesis of NEC. Firstly, this study confirmed that the expression of CXCL14 decreased in the intestinal tract of NEC children. Secondly, the experiments results showed that CXCL14 could ameliorate the inflammatory injury of intestinal tissue through the suppressive effect on the expression of TNF-α and INF-γ in vivo. Finally, we explained that activation of the TLR4 can reduce the expression level of CXCL14 in the intestinal tissue of mouse pups. Collectively, our study suggested that CXCL14 may negatively regulate the inflammatory response in intestinal tissue and play an essential role in NEC development and progression.

Publication types

  • Retracted Publication

MeSH terms

  • Animals
  • Anti-Inflammatory Agents
  • Chemokines, CXC / therapeutic use
  • Enterocolitis, Necrotizing* / drug therapy
  • Enterocolitis, Necrotizing* / etiology
  • Enterocolitis, Necrotizing* / pathology
  • Humans
  • Incidence
  • Infant, Newborn
  • Mice
  • Tumor Necrosis Factor-alpha / metabolism
  • Tumor Necrosis Factor-alpha / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • CXCL14 protein, human
  • CXCL14 protein, mouse
  • Chemokines, CXC
  • Tumor Necrosis Factor-alpha